Browsing Tag
Breztri Aerosphere
2 posts
Phase III evidence elevates BREZTRI in the competitive asthma landscape
Phase III data position AstraZeneca Plc’s BREZTRI for asthma growth. Discover the strategic, financial, and competitive implications.
February 15, 2026
Trump announces second MFN pricing deal as AstraZeneca slashes drug costs for millions
AstraZeneca to offer most-favored-nation drug prices to U.S. Medicaid and invest $50B in American pharma manufacturing. Find out what it means for patients.
October 13, 2025